STAT3, as one of the signal transducers and activators of transcription (STAT) family members, is highly activated in melanoma, breast cancer, lung cancer, pancreatic carcinoma and glioma, suggesting that STAT3 may be an effective target for tumour therapy.9 This evidence concerns the gene STAT3 and central nervous system cancer.